Stocks of the Hour: Jindalee Lithium, Algorae Pharmaceuticals, Canyon Resources

Informed Investor07-31


To register for Friday's webinar click here.

Jindalee Lithium (ASX:JLL) announced that battery-grade lithium carbonate has been successfully produced from ore from the McDermitt Lithium Project. All steps of the processing flowsheet for the Project from ore beneficiation and leaching to purification and production of battery-grade lithium carbonate are now validated. Shares are trading 13.46 per cent higher at 29.5 cents.

Algorae Pharmaceuticals (ASX:1AI) has released positive results for its drug AI-116. It showed significantly better results in reducing brain cell damage than an existing dementia drug in laboratory tests. Shares are trading 33.33 per cent higher at 1.2 cents.

Canyon Resources (ASX:CAY) has signed a mining convention for the Minim-Martap Bauxite Project in Cameroon. This agreement outlines how Canyon's subsidiary can mine and export alumina and bauxite once it receives a mining permit. Shares are trading 2.67 per cent higher at 7.7 cents.  
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment